| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| Dukiprubart | SGC-001; ZYB-0069 | Phase 2 Clinical | Beijing Sungen Biomedical Technology Co Ltd | Anterior Wall Myocardial Infarction; Myocardial Infarction; ST Elevation Myocardial Infarction | 상세 |
| Tasquinimod | ABR-215050; TASQ; ABR-5050 | Phase 2 Clinical | Active Biotech Ab | Carcinoma, Renal Cell; Hormone-Resistant Prostate Neoplasms; Multiple Myeloma; Ovarian Neoplasms; Polycythemia Vera; Primary Myelofibrosis; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Stomach Neoplasms; Thrombocythemia, Essential | 상세 |